Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 439,049 shares at $155.86 ($68.5M) on 2021-04-12, disclosed to the SEC on 2021-04-14.
Open-market sale of $68.5M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $151.80 | 1,553 | $236K | 0.3% |
| 2 | $151.80 | 1,553 | $236K | 0.3% |
| 3 | $153.25 | 19,864 | $3.0M | 4.4% |
| 4 | $153.69 | 11,053 | $1.7M | 2.5% |
| 5 | $153.69 | 11,053 | $1.7M | 2.5% |
| 6 | $155.25 | 16,513 |
| $2.6M |
| 3.7% |
| 7 | $155.25 | 16,513 | $2.6M | 3.7% |
| 8 | $155.86 | 23,878 | $3.7M | 5.4% |
| 9 | $155.86 | 23,878 | $3.7M | 5.4% |
| 10 | $153.78 | 5,593 | $860K | 1.3% |
| 11 | $153.78 | 5,593 | $860K | 1.3% |
| 12 | $154.68 | 4,424 | $684K | 1.0% |
| 13 | $154.68 | 4,424 | $684K | 1.0% |
| 14 | $155.57 | 10,757 | $1.7M | 2.4% |
| 15 | $155.57 | 10,757 | $1.7M | 2.4% |
| 16 | $156.93 | 43,728 | $6.9M | 10.0% |
| 17 | $156.93 | 43,728 | $6.9M | 10.0% |
| 18 | $157.39 | 41,020 | $6.5M | 9.4% |
| 19 | $157.39 | 41,020 | $6.5M | 9.4% |
| 20 | $158.51 | 284 | $45K | 0.1% |
| 21 | $154.49 | 6,606 | $1.0M | 1.5% |
| 22 | $154.49 | 6,606 | $1.0M | 1.5% |
| 23 | $155.46 | 17,637 | $2.7M | 4.0% |
| 24 | $155.46 | 17,637 | $2.7M | 4.0% |
| 25 | $156.39 | 10,591 | $1.7M | 2.4% |
| 26 | $156.39 | 10,591 | $1.7M | 2.4% |
| 27 | $157.28 | 6,047 | $951K | 1.4% |
| 28 | $157.28 | 6,047 | $951K | 1.4% |
| 29 | $158.00 | 20,101 | $3.2M | 4.6% |
| Total | $156.06 avg | 439,049 | $68.5M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |